Bank of Nova Scotia
IONS icon

Bank of Nova Scotia’s Ionis Pharmaceuticals IONS Stock Holding History

Bank of Nova Scotia’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,189
Closed -$331K – 1148
2025
Q4 		$331K Buy
4,189
+680
+19% +$51.2K ﹤0.01% 1006
2025
Q3 		$230K Buy
+3,509
New +$171K ﹤0.01% 979
2024
Q3 		– Sell
-51,879
Closed -$2.47M – 1036
2024
Q2 		$2.47M Buy
+51,879
New +$2.13M ﹤0.01% 599
2023
Q3 		– Sell
-78,042
Closed -$3.2M – 1030
2023
Q2 		$3.2M Buy
78,042
+36,636
+88% +$1.41M 0.01% 436
2023
Q1 		$1.48M Buy
41,406
+10,406
+34% +$391K ﹤0.01% 619
2022
Q4 		$1.17M Buy
+31,000
New +$1.3M ﹤0.01% 774
2022
Q1 		– Sell
-601,883
Closed -$18.3M – 1249
2021
Q4 		$18.3M Buy
601,883
+589,568
+4,787% +$18.6M 0.03% 400
2021
Q3 		$413K Sell
12,315
-1,220
-9% -$46K ﹤0.01% 1050
2021
Q2 		$540K Buy
+13,535
New +$530K ﹤0.01% 958
2018
Q2 		– Sell
-75,000
Closed -$3.31M – 901
2018
Q1 		$3.31M Buy
75,000
+41,201
+122% +$2.09M 0.02% 460
2017
Q4 		$1.7M Sell
33,799
-8,201
-20% -$450K 0.01% 652
2017
Q3 		$2.13M Buy
42,000
+12,000
+40% +$629K 0.01% 571
2017
Q2 		$1.53M Buy
+30,000
New +$1.4M 0.01% 685
2017
Q1 		– Sell
-300,000
Closed -$14.3M – 904
2016
Q4 		$14.3M Buy
+300,000
New +$11.9M 0.07% 164

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of Nova Scotia's IONS Position: Q1 2026 in Review

Bank of Nova Scotia sold out of Ionis Pharmaceuticals (IONS) in Q1 2026, closing a stake of 4,189 shares — an estimated $331K sold.

Bank of Nova Scotia first reported a position in IONS in Q4 2016 and held it in 14 quarters. The position peaked at $18.3M in Q4 2021. 494 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Bank of Nova Scotia reported no remaining Ionis Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Bank of Nova Scotia sold 4,189 Ionis Pharmaceuticals shares in Q1 2026, an estimated $331K.
  • Bank of Nova Scotia first reported a position in Ionis Pharmaceuticals in Q4 2016 and held it in 14 quarters.
  • Bank of Nova Scotia's Ionis Pharmaceuticals position peaked at $18.3M in Q4 2021.
  • 494 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Bank of Nova Scotia's 13F filing for Q1 2026, filed 14 May 2026.